Observational studyAJNR. American journal of neuroradiology2025
Clinical Impact of Sinus CT Surveillance Imaging among Febrile Neutropenic Patients: A Retrospective Observational Study.
Observational study in AJNR. American journal of neuroradiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposeAt many institutions, CT imaging is routinely performed among febrile neutropenic patients to identify fever sources. We examined the impact of surveillance sinus CT imaging results on the clinical management of febrile neutropenic patients with hematologic disorders undergoing chemotherapy or bone marrow transplant. MATERIALS AND
methodsFollowing internal review board approval, we identified consecutive CT sinus examinations performed among patients with febrile neutropenia in the setting of chemotherapy or bone marrow transplant for hematologic malignancy and other hematologic disorders between January and March of 2017. CT sinus reports were reviewed for the presence or absence of sinus inflammatory changes. Electronic medical records (EMRs) for each patient at the time of each scan were reviewed for clinical parameters, including type of hematologic malignancy or hematologic disorder, treatment approach, fever >100.4F, absolute neutrophil count <1500 cells/μL, and presence of clinical features of sinusitis. EMRs were reviewed for any changes in antibiotic coverage on the basis of scan results, whether positive or negative, along with results of cultures, if performed. Clinical notes from hematology-oncology specialists as well as infectious disease and otolaryngology consultants, if performed, were also reviewed. Results were tabulated and recorded.
resultsOf 127 CT sinus scans performed on 87 patients, including 41 males and 46 females, with a mean age of 54 ± 18 years, 15 (11.8%) reported imaging findings of acute sinusitis, while the remaining 112 (88.2%) showed no suspicious imaging features of acute sinus inflammation. Of 15 scans with evidence of acute sinusitis, 4 coincided with a change in antimicrobial management based on clinical, not imaging, findings. Of the 112 scans without imaging findings of acute sinusitis, 18 coincided with a change in antimicrobial management based on clinical concerns and/or imaging evidence of infection outside the sinonasal cavity. Of the 87 patients scanned, thirty (34%) had multiple examinations during the investigated 3-month period.
conclusionsCT sinus imaging results, positive or negative, did not directly alter clinical management in this patient population. Appropriate value-based imaging in this vulnerable population is an evolving concept; however, current results suggest routine sinus CT may be a low-yield examination in the setting of febrile neutropenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.